Published in Gene Therapy Weekly, August 8th, 2002
The company's initial screen was for genes linked to age-related diseases, testing pooled samples of DNA from nearly 1500 individuals across the 25,000 markers. A subsequent screen compared DNA from more than 1000 melanoma patients and controls across the SNP assay set to identify genes linked to melanoma, a serious form of skin cancer.
Sequenom's genome-wide marker set, the largest of its kind available to date, consists of 25,000 gene-based single...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.